A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

Abstract Background Atractylodes lancea (Thunb) DC. (AL) and bioactive compounds β-eudesmol and atractylodin have been demonstrated in the in vitro and in vivo studies for their potential clinical use in cholangiocarcinoma. The study was a randomized, double-blinded, placebo-controlled phase I clini...

Full description

Bibliographic Details
Main Authors: Inthuon Kulma, Luxsana Panrit, Tullayakorn Plengsuriyakarn, Wanna Chaijaroenkul, Siriprapa Warathumpitak, Kesara Na-Bangchang
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Atractylodes lancea
β-Eudesmol
Atractylodin
Cholangiocarcinoma
Immunomodulatory activity
Online Access:https://doi.org/10.1186/s12906-020-03199-6

Internet

https://doi.org/10.1186/s12906-020-03199-6

Similar Items